news roundup

BBK Survey: Physicians Do Refer Patients into Trials

With more than two-thirds of physicians surveyed indicating they have referred a patient to a clinical study, and half of the sponsors surveyed assuming the exact opposite, BBK's latest survey provides additional insights into recruitment strategies.

Two Large CROs Each Announce FSP at DIA

Both Syneos Health and Parexel announced enhanced functional service provider (FSP) models available for sponsors at DIA last week.

CRO PHASTAR Aligns with Medidata

CRO PHASTAR announced that it has entered into a technology partnership with Medidata Solutions and will deploy several solutions from the Medidata Rave Clinical Cloud including Rave EDC, Coder, eCOA, and RTSM.

Articles

FDA Answers eISF Questions

In this article, the author asks the FDA about GCP electronic investigator site files to allay sponsors fears of adoption.

Master Protocols in Oncology, Where Will FDA Land?

Jeffrey Hodge, VP of Development Solutions and Head of the Oncology Center of Excellence at IQVIA, looks at the current state of FDA’s Master Protocol Guidance in oncology drug development.

Blog Posts

The Changing Needs of Mid-Size Sponsors

Becky Carpenter, Head of North America/Euro Operations at WuXi Clinical, a newly formed CRO, discusses the evolution of the mid-sized pharma and CRO space.

Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com